Samyang Holdings, at the International Master Course on Aging Science (IMCAS), hosts a symposium on lifting thread "Croquis."
SEOUL, South Korea, Feb. 19, 2024 /PRNewswire/ -- Samyang Holdings BioPharm Group (CEO Lee Young-jun) announced that it had conducted a symposium on the unique features and procedural techniques of the lifting thread "Croquis" at the International Master Course on Aging Science (IMCAS) 2024, the world's largest international aesthetic and plastic surgery congress held in Paris, France.
- - Sharing the effects and safety of facial and neck fat redistribution using the Croquis double lifting technique.
- - CEO Lee Young-jun pledges to expand global market presence with products focusing on high-polymer substance research and development.
- SEOUL, South Korea, Feb. 19, 2024 /PRNewswire/ -- Samyang Holdings BioPharm Group (CEO Lee Young-jun) announced that it had conducted a symposium on the unique features and procedural techniques of the lifting thread "Croquis" at the International Master Course on Aging Science (IMCAS) 2024, the world's largest international aesthetic and plastic surgery congress held in Paris, France.
- Developed by Samyang Holdings, a leader in the field of biodegradable sutures, the product obtained the 2019 European Medical Devices Directive (MDD) certification.